Pathways are integral to systems biology. Their classical representation has proven useful but is inconsistent in the meaning assigned to each arrow (or edge) and inadvertently implies the isolation of one pathway from another. Conversely, modern high-throughput (HTP) experiments offer standardized networks that facilitate topological calculations. Combining these perspectives, classical pathways can be embedded within large-scale networks and thus demonstrate the crosstalk between them. As more diverse types of HTP data become available, both perspectives can be effectively merged, embedding pathways simultaneously in multiple networks. However, the original problem still remainsthe current edge representation is inadequate to accurately convey all the information in pathways. Therefore, we suggest that a standardized and well-defined edge ontology is necessary and propose a prototype as a starting point for reaching this goal.
Uniting classical pathways and modern networks
In biology, a pathway refers to a sequence of reactions, usually controlled and catalyzed by enzymes, by which one organic substance is converted to another. Biological pathways are an important component of systems biology. The classical representation of these pathways provides varied, mechanistic associations between many proteins. Conversely, modern high-throughput (HTP) experiments and large-scale databases have given rise to standardized networks that provide a somewhat different perspective on pathways. By combining and comparing these perspectives, classical biochemical pathways can be embedded into large-scale networks. This reveals two problematic issues with classical pathways: (i) the components included and their exact symbolic representation (e.g. the meaning of each arrow) in the same pathway that has been documented in different databases are often inconsistent; and (ii) pathways are isolated from one another in classical representations, which de-emphasizes crosstalk. By contrast, embedded pathways offer completely uniform representations and relate network statistics such as average degree or diameter consistently. However, they are more limited in the level of detail of the mechanistic biochemistry that they can convey. As more diverse types of HTP data become available, it will be possible to embed classical pathways simultaneously in many large-scale networks, effectively merging both approaches. To accomplish this, a precise edge (or arrow) ontology needs to be defined. For illustrative purposes, we propose a prototype of ontology that provides an unambiguous representation of the edges connecting biomolecules and that also describes higher-level relationships among edges. Here, we demonstrate the usefulness of the simple-edge ontology on four diverse types of pathways. We do not intend to provide a complete ontology here but, rather, we want to stimulate people working in this field to continue building upon existing knowledge until a complete ontology is achieved.
Pathway databases and limitations
During the past decade, an increasing number of pathway databases have been established to document the everexpanding knowledge regarding established pathways. Some of these pathway databases are organism specific. For example, EcoCyc [1] describes the genome and the biochemical machinery of Escherichia coli (K12 MG1655). A few other pathway databases focus on a specific type of disease or disorder, for example, The Cancer Cell Map (http://cancer.cellmap.org) or GOLD.db [2] . The majority of these pathway databases cover a certain functional area that occurs in multiple organisms. Furthermore, such databases can often be approximately divided into three categories: (i) those containing metabolic pathways (e.g. KEGG [3] , WIT [4] , BioCyc [5] , MetaCyc [6] and GenMAPP [7] ); (ii) those containing signal-transduction (signaling) pathways {e.g. BioCarta (http://biocarta.com), STKE (http:// stke.sciencemag.org), Pathways Knowledge Base (http:// ingenuity.com) and Reactome [8] }; and (iii) those containing both (e.g. KEGG, BioCarta and Reactome). Excellent recent reviews on these pathway databases can be found elsewhere [9, 10] .
Although the afore-mentioned databases provide valuable resources for studying associations between proteins, they are hampered by several limitations. First, the same pathways documented in different databases are often inconsistent. In many cases, a pathway is described by including a few core components first. The decision of whether to include additional components in the given pathway is usually empirically determined, based on the expert curators' knowledge and experience. Therefore, the boundary of a pathway is usually vague. The consequence is that the number of components in the same pathway in different databases varies greatly (See Supplementary Table S1 ).
Second, these pathways are isolated in classical representations. This is the consequence of the traditional reductionist approaches to molecular biology, whereby genes and pathways are investigated as isolated entities. However, from the perspective of modern systems biology, the interactions between biological pathways must be studied to understand how biological systems function. On the systems level, the crosstalk between pathways seems to be particularly important but lacks substantial study. Although there have been efforts to integrate them, such as in the Boehringer Mannheim Biochemical Pathways wall chart, many aspects of the relationships between pathways have yet to be systematically identified and incorporated.
Third, the classical representations of pathways use symbols that lack a precise definition. The same symbol is often used to represent a variety of functions. For example, arrows are used to represent direct interactions in some circumstances but, in others, they are also used to represent translocation to a different subcellular compartment. Although this might not cause problems for laboratories that focus on individual pathways, these notations must be precisely defined to perform analyses on pathways on larger scales. A structured vocabulary or ontology of these symbols should be developed to ameliorate this problem.
Recent advent of network biology
A particularly novel concept in the post-genomic era is the idea that a living cell can be viewed as a complex network of biomolecules. Indeed, a biomolecular network can now be rendered as a collection of nodes and edges. Nodes represent biomolecules such as proteins, genes and metabolites, whereas edges represent the types of associations between two nodes, such as physical interactions and coexpression of mRNAs. The combined functions and interactions between these networks constitute the behavior of the cell. Mapping and understanding biomolecular networks represents the first step towards modeling how a cell actually operates.
As a result of recent genome-wide HTP experiments, including large-scale yeast two-hybrid screens and microarray experiments, many types of networks have been mapped, including protein-protein interaction, expression, regulatory, metabolic and signaling networks. For example, protein-protein interaction networks have been experimentally determined in Saccharomyces cerevisiae [11] [12] [13] [14] [15] , Caenorhabditis elegans [16] , Drosophila melanogaster [17] , Homo sapiens [18, 19] , Plasmodium falciparum [20] and Helicobacter pylori [21] . The availability of such well-mapped networks has enabled us to compare and contrast them in terms of global and local topology, in addition to relating the structural properties of these networks to protein properties such as function and essentiality.
Topological analysis of networks provides quantitative insight into their basic organization. Different network statistics have been designed to capture the characteristics of network topology (see Supplementary Table S2 ). Despite the seemingly vast differences between biomolecular networks, they are found to share common features with respect to network topology. Barabá si et al. [22] proposed a 'scale-free' model in which the degree distribution in many large networks follows a power-law distribution
What is remarkable about this distribution is that, whereas most of the nodes within these networks have few links, a few of these nodes, classified as hubs, are exceptionally well-connected. Concurrently, Watts and Strogatz [23] found that many networks also have a 'small-world' property, meaning they are defined as being both highly clustered and containing small characteristic path lengths.
Network analysis has provided new quantitative insights into protein properties, cellular dynamics and other biological problems. For example, research has shown that hubs in a network are more likely to be essential proteins, and there is debate over whether hubs tend to evolve slower [24] [25] [26] . Furthermore, different motifs have been implicated in different stages of dynamic transitions of a network [27] .
Comparisons between classical and embedded pathways Large-scale networks can be constructed using different types of data from HTP experiments: protein-protein interaction networks from yeast two-hybrid screens, and co-expression networks from microarray experiments provide apt examples of this. For each classical pathway, the corresponding sub-network can be extracted from the entire network by mapping the core components in the classical pathway onto the network of biomolecules. From a network point of view, this mapping can also be regarded as embedding pathway components into the network. To differentiate from the classical pathways, we refer to these sub-networks as embedded pathways ( Figure 1 ). The core components of a classical or embedded pathway are defined as the biomolecules in the KEGG pathway diagram. For this review, we used KEGG because of its high quality, as pointed out by Wittig et al. [28] .
The Notch pathway can be used as an example to illustrate embedded pathways because of its elegance and simplicity. The Notch signaling pathway is a highly conserved pathway for cell-cell communication that is involved Opinion TRENDS in Biochemical Sciences Vol.32 No.7 in the regulation of cellular differentiation and proliferation. We constructed core and extended embedded pathways by collecting the 22 core-protein components listed in KEGG and mapping them onto the large-scale protein-protein interaction network deposited in the Human Protein Reference Database (HPRD) [29] (Figure 1 ). The HPRD interactions are manually curated by expert biologists to reduce errors.
Comparisons between classical and core embedded Notch pathways reveal several differences. First, the classical pathway contains directed and undirected edges ( Figure 2a ). Directed edges often represent activations, such as the edge between Delta and Notch. They also represent translocation to a different cellular compartment, for example, the edge between Notch and the Notch intracellular domain (NICD). Undirected edges often represent an interaction between two components, such as the edge between CSL (recombination signal-binding protein for immunoglobulin kJ region-like) and SKIP (SNW domain-containing 1). By contrast, the edges between components in the embedded pathway are uniform ( Figure 2b ). In this case, they are protein-protein interactions. Although the edge representation in the core embedded pathway is more consistent, it loses information encoded in classical pathways.
Second, although most of the edges are common between both representations, some appear only in one representation. The core embedded pathway also reveals 12 new interactions that are not found in the KEGG classical pathway. Conversely, two edges in the KEGG pathway are not present in the core embedded pathway: between Notch and Dishevelled (DVL) and between Notch and TACE (ADAM metallopeptidase domain 17), which indicates either that the protein-protein interaction map is incomplete or that these interactions take place through an intermediate (Figure 2a and b) .
Compared with the classical pathway, the core embedded pathway has two advantages. First, it can indicate which isoform is responsible for an interaction. For example, in the interaction between Notch and Numb, the embedded pathway identifies that Notch1 (Entrez ID: 4851) -but not the other three isoforms -interacts with Numb ( Figure 2c ). By contrast, the current version of the classical pathway collapses multiple protein isoforms into one single node.
Second, extended embedded pathways can systematically represent new components involved in classical pathways. The extended embedded Notch pathway identifies 218 new proteins that are potentially involved in the Notch pathway by extracting the immediate interacting partners of these core components (Figure 2d ). It is increasingly evident that the Notch pathway is subject to a wide array of regulatory influences, from those that affect ligand-receptor interactions to those that govern the choice of Notch target genes [30, 31] . For example, the classical Notch pathway in KEGG shows that DVL inhibits Notch. In the HTP networks, Notch and DVL do not interact directly but through an intermediate protein, namely, glycogen synthase kinase 3b (GSK-3b). DVL and GSK-3b are known to be involved in the Wnt pathway. The interaction of Wnt with Frizzled receptors activates a cascade for which DVL is required. Activated DVL inhibits GSK-3b [32] . The relationship between GSK-3b and Notch has been found by Espinosa et al. [33] , who report that GSK-3b phosphorylates Notch2 both in vitro and in vivo. They suggest that GSK-3b can partially mediate crosstalk between Wnt and Notch pathways. In this instance, the interaction between components is not necessarily linear, and components potentially involved with but outside the immediate pathway can also be shown. In this type of representation, the edges are mapped according to data from HTP experiments such as yeast two-hybrid screens of protein-protein interactions or from large-scale databases. In the example shown here, a core embedded pathway contains the same set of core components (A-E, blue nodes) as in the classical pathway in part (a), including the edges linking them together. However, the extended embedded pathway (b) also contains the nodes (yellow) that are immediately linked to the core components. Note that different numbers of edges have been intentionally drawn among the blue nodes to emphasize the potential for the occurrence of differences between classical and embedded pathways. In this example, A is shown to interact with E in the embedded pathway, whereas no such interaction is shown in the classical pathway. This is because A does not inhibit or cause E to perform a chemical reaction and, therefore, no representation of this is required in the classical pathway. However, the interaction in the embedded pathway could indicate that A functions as a scaffold for E within the pathway but does not necessarily imply that it causes E to perform a reaction.
Despite these advantages, the embedded pathway suffers substantial information loss by restricting the edges to describing physical interaction. One way to circumvent this problem would be to overlay additional types of large-scale data onto the network by defining different types of edges. For example, it has been found that Notch down-regulates Presenilin 1 (PSEN). This interaction is particularly interesting because PSEN is a component of the g-secretase complex, which cleaves the intracellular domain of Notch, triggering the rest of the pathway. By laying the regulatory network on top of the protein-protein interactions, this feedback loop is highlighted [34] .
Relating network properties in embedded pathways
Because of the heterogeneity of the edges and the incomplete nature of classical pathways, it is difficult to relate the mathematical quantities of modern network biology to these pathways. However, the same task becomes straightforward when applied to the embedded pathways created by mapping the core components of classical pathways onto large-scale networks. We provide an illustrative example as Supplementary material, showing how the topological quantities in modern network biology can lead to new insights into biochemical pathways. We found that signaling pathways from metabolic pathways have significantly different network topologies (Supplementary Table S3 and Figure S1 ). This difference has enabled us to successfully differentiate signaling pathways from metabolic pathways.
It is also interesting to note that the topological quantities between two of the same type of pathway (signaling or metabolic) can be different even when they contain a similar number of core components, as illustrated by Notch versus Hedgehog extended embedded pathways (Figure 3 ). Do these differences reveal anything about the underlying mechanisms of Notch and Hedgehog? Initially, we must consider the possibility that these differences are merely artifacts, that is, that the protein-interaction network is incomplete and, as the map expands, such differences will disappear. Although this is plausible, an alternative explanation is that these differences reflect real biological differences. This might be explained by the different regulatory mechanisms used by the two pathways. For example, Notch pathway might be subject to more regulatory influences. Indeed, although our analysis indicates that whereas the core components of Notch embedded pathway have an average of $21 interacting partners, those of the Hedgehog embedded pathway have just $7 ( Figure 3) .
In addition to global inferences, topological measures can be used to identify nodes of particular importance or function (see Supplementary Table S6 for detailed definition of network topologies). For instance, hubs (nodes of high degree) in regulatory networks correspond to master regulators [35] . Conversely, bottlenecks (nodes of high 'between-ness') often correspond to nodes that function as important information conduits, particularly in directed networks such as metabolic networks (in which metabolites flow between nodes) or signaling networks (in which information in the form of activations flows between nodes) [36] . Furthermore, these nodes most likely function as connectors between pathways, thereby mediating crosstalk (see later). Likewise, essential regulators can be identified by searching for composite hubs (i.e. nodes that have many interacting partners both in the metabolic and signaling network [37] ). A combination of network stat- istics across different networks can be employed to identify several nodes that might have key roles in the biological function of cells. As knowledge of the different types of networks increases, an unambiguous and rigorous definition of protein function will eventually emerge from a combination of topological measures and network position [38] . That is, the importance of a protein is not only defined by its classical biochemical function, but also its position in the network. For example, hubs in Notch pathway include the histone deacetylases (HDAC), cAMP response elementbinding protein (CREB)-binding protein (CREBBP), E1A binding protein p300 (EP300) and DVL2; all of these nodes have crucial roles in the regulation of the pathway. Furthermore, axis inhibitor 1 (AXIN1) is a bottleneck in both the Hedgehog and the Wnt pathways, indicating its importance for the information flow both within and between these pathways.
Examining crosstalk between embedded pathways
In living organisms, pathways are not isolated entities. From a systems biology perspective, pathways are linked together through crosstalk to perform biological functions as a system. In biology, the term 'crosstalk' refers to the phenomenon that signal components in signal transduction can be shared between different signaling pathways, and responses to a signal-inducing condition (e.g. stress) can activate multiple responses in the cell or organism. This crosstalk can be exemplified by protein kinase C, which is shared by the mitogen-activated protein kinase (MAPK), calcium, phosphatidylinositol, Wnt and vascular endothelial growth factor (VEGF) signaling pathways. However, because classical pathways only contain core components, they are insufficient to study crosstalk. This is evidenced by the few overlaps between classical pathways, which serve as indicators of the extent of crosstalk between them (Figure 4 and Supplementary Table S4) . By contrast, embedded pathways provide an excellent platform to examine crosstalk because components of pathways are essentially embedded within a bigger network, which enables systematic identification of overlapping and linking components. Figure 4 and Supplementary Table S4 show the overlaps between embedded pathways that correspond to signaling pathways in humans. The overlaps between both the core and the extended embedded pathways have been examined: the larger the overlap between embedded Table S6 for detailed definition of network topologies). The clustering coefficient (C), degree (K) and 'between-ness' (B). Values are all significantly higher in the Notch pathway (highlighted in red) than in the Hedgehog pathway. Note, K, C and B are statistical parameters used to measure network topologies (see Supplementary Table S2 for full definitions). 7 pathways, the more crosstalk takes place between the two pathways. Although most of the core embedded pathways do not overlap significantly, the corresponding extended embedded pathways often show a significant increase in overlap (Supplementary Table S4 ). These results indicate that many proteins exist as liaison components between pathways, and all the signaling pathways can be connected with just one degree of separation. A careful examination of these intermediate proteins might be useful in unraveling the mechanisms by which different pathways are related to each other.
Opinion

TRENDS in Biochemical Sciences
Developing a simple version of edge ontology for pathways As mentioned, classical pathway representations are often ambiguous because they use the same symbol to represent different functions. In the post-genomic era, this problem is further confounded by the emergence of various types of HTP data, which reveal different relationships between pathway components. In addition to protein-protein interaction networks, the core components of a pathway can also be mapped onto other types of networks, such as gene expression and regulatory networks. Simple edges (e.g. arrows) that are traditionally used in classical pathway representations might not be sufficient to meet the challenges of integrating these heterogeneous datasets. To perform large-scale mining of pathways, a precise edge ontology (or arrow ontology) must be developed to represent different types of relationships between pathway components.
To make things more complicated, many pathway databases are currently available [9, 39] . Unfortunately, they do typically not share data models, file formats or access method. To foster sharing of these different information sources, several Extensible Markup Language (XML) exchange formats have been developed. System Biology Markup Language (SBML) [40] and CellML [41] focus mainly on quantitatively simulating concentrations of pathway components. The Proteomic Standards Initiative's Molecular Interaction (PSI-MI) [42] is an exchange format for molecular interaction, and the Biological Pathway Exchange (BioPAX) [43] is a more general format used to describe biological pathways.
Much effort has been devoted to developing consistent representations of pathways; however, most of these efforts focus on enumerating diverse types of edges. BioPAX has been developing an ontology of interactions that reveals relationships between edges. To perform large-scale mining of pathways, making explicit the relationships between edges is an important step for elucidating the transitions and reactions between molecules. A precise edge (or arrow) ontology might also help improve pathway representation by highlighting both different types of relationships between pathway components and the knowledge of that relationship.
As an example, phosphorylation, ubiquitylation, glycosylation and methylation can all be viewed as types of reactions by transferring 'tags' to target proteins. Thus, an Figure 5 . Biochemical pathways redrawn using the new edge ontology. We believe that pathways can be redrawn in a more representative manner using our proposed new edge ontology. Four different types of pathway are shown to highlight how more information can be conveyed using a more descriptive ontology. In particular, compare (a) with Figure 2a . In this case, for example, the interaction between TACE and Notch is more clearly seen to be a cleavage reaction in (a), whereas the type of interaction ontology of edges that not only enumerates different types of edges but also classifies the edges into groups should be developed to capture this information. This explicit hierarchy of relationships can be exploited to enable accurate computational analysis without losing the expressiveness of the classical representation. For example, some pathway interactions can be represented by specific symbols, such as serine phosphorylation. However, translation to a more general interaction, such as 'tagging' that leads to activation, can be employed to perform high-level analysis of the pathway or to compare multiple pathways represented at a different level of specification.
Here, we propose a simple version of edge ontology to illustrate how we could deal with this issue in the future. This ontology provides both an unambiguous definition of the interactions and defines a hierarchy of those interactions. In particular, the hierarchy of interactions might be useful to obtain multiple views of a pathway, from a general one to a more specific one. It also contains symbols that might help the graphical representation of interactions. Please note, this ontology is far from complete. We foresee that the formidable goal of constructing a complete ontology for pathways would take multiple groups many years to achieve. However, this simple ontology could be used as a starting point from which we hope a complete ontology can be built. We also realize that a consistent representation of nodes is equally important; however, this problem can be largely solved by using Gene Ontology (GO) [44] . The GO provides a controlled vocabulary for describing gene and geneproduct attributes in any organism, and hence could be used as an approximate node ontology. Here, we focus on edge ontology.
The edge ontology we propose is presented in Table 1 . We use different shapes, symbols and colors to represent diverse types of interactions between pathway components. We also define a simple hierarchy of interactions from general ones to more specific ones. The first level divides directed from undirected interactions, whereas the second level highlights the main mechanisms of interaction, which are, in turn, defined in more detail in the third level. The fourth level further specifies some of the interaction types. The edges in the second level have different shapes, whereas those in the third level are represented by different colors. Further specifications can be defined by adding annotations on the edge, such as those in the fourth level. Nearly all the edges connect two components of the pathways, such as proteins and molecules, except that the 'catalysis' edge connects a pathway component to a 'chemical reaction' edge. This enables us to properly describe metabolic pathways that typically display a sequence of chemical reactions in which enzymes take part.
For example, a black arrow is used to indicate a 'tagging' interaction, meaning an interaction that binds a molecule to a pathway component. If we know the type of interaction in more detail, different colors can be used to describe different 'tagging' mechanisms: red for phosphorylation, blue for ubiquitylation and so on. In many cases, however, the tagging mechanism activates proteins; to highlight that some tagging mechanisms inhibit proteins, a solid vertical line is used instead of an arrowhead. To add further detail to the relationship, an annotation on the edge can be used, such as 'ser' for serine phosphorylation and 'N' for N-linked glycosylation. It is worth noting that symbols from different levels can be used concurrently in the same pathway. This might be used to emphasize the level of understanding of the interaction.
For illustration purposes only, we provide four examples of the application of this edge ontology: the Notch pathway, the citric acid cycle, the JAK-STAT signaling pathway and the caspase cascade pathway. Figure 5 shows the classical pathways redrawn according to our new edge ontology.
Concluding remarks
Although classical representations of biochemical pathways can provide in-depth views of isolated sets of genes, the network approach is capable of analyzing pathways on three different levels: whole system (crosstalk), whole network and individual nodes. Whereas embedding pathways to large-scale protein-protein interaction networks enables easy comparison of properties across, between and within pathways, we also experience substantial information loss. One way to circumvent this problem would be to overlay additional types of HTP data onto the pathway by defining different types of edges.
To properly analyze this type of multilayered network, a precise edge ontology must be defined. The edge ontology should provide an unambiguous representation of the relationships between biomolecules in addition to revealing relationships between the edges. However, even a welldefined edge ontology suffers the limitation of lacking explicit temporal information. Properly incorporating explicit temporal information will be the next challenge in the representation of pathways.
between the two components is not depicted in Figure 2a . Note, solid ellipses have been used to enclose complexes, and the complexes are also linked by solid edges to indicate known physical interactions. In other contexts, different edges can be used given the uncertainty over the types of actual association. Table 1 for key). The main chemicals that take part in the interactions are shown in broken ellipses. We found direct interaction between IDH3A, IDH3B and IDH3G; however, the specific type of interaction involved in this complex, such as that from tandem affinity purification (TAP)-tagging experiments, is not known. Thus, we could use 'association' or 'binding or association' defined in the edge ontology to represent the pair-wise relationship between proteins in this complex. Abbreviations: ACO1, aconitase 1; ACO2L, aconitase 2; CS, citrate synthase; FH, fumarate hydratase; IDH, isocitrate dehydrogenase; MDH, malate dehydrogenase; OGDH, oxoglutarate (a-ketoglutarate) dehydrogenase (lipoamide); OGDHL, oxoglutarate dehydrogenase-like; SDHA, SDHB, SDHC and SDHD, succinate dehydrogenase complex, subunit A, B, C and D, respectively; SUCLA2, succinate-CoA ligase (ADP-forming), b subunit; SUCLG1, succinate-CoA ligase (GDPforming), a subunit; SUCLG2, succinate-CoA ligase (GDP-forming), b subunit. If so, please contact our Global Rights Department with details of how and where the requested material will be used. To submit a permission request online, please visit:
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